Skip to content

Clinical trials

Phase 1/2 Lymphoma, T-Cell, Cutaneous trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Phase: Phase 1/2 Country / region: United States Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20022
20035
20053
20063
20072
20082
20091
20102
20111
20121
20134
20161
20173
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated10
Active, not recruiting2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center4
National Cancer Institute (NCI)4
Northwestern University4
Mayo Clinic2
Memorial Sloan Kettering Cancer Center2
UNC Lineberger Comprehensive Cancer Center2
AbbVie (prior sponsor, Abbott)1
Abramson Cancer Center at Penn Medicine1
Ahmed Sawas1
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous42
Mycosis Fungoides28
Sezary Syndrome25
Hodgkin Disease23
Lymphoma, Follicular23
Lymphoma, Large B-Cell, Diffuse22
Leukemia, Lymphocytic, Chronic, B-Cell21
Lymphoma, B-Cell, Marginal Zone21
Lymphoma, Non-Hodgkin21
Lymphoma, Mantle-Cell20

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.